Merck, a leading science and technology company, today announced that Health Canada has approved MAVENCLAD™ (Cladribine Tablets) as monotherapy for...
Read more
Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled...
Read more
AgriLabs® today announced that it has developed a set of master seeds for a replication-deficient human adenovirus vector that expresses...
Read more
Personalized medicine is taking new and powerful forms in the field of immunotherapy. The technology behind making customized tumor-destroying cells,...
Read more
The letter of intent signed to develop this oil & gas company's large acreage in the red-hot Permian Basin would...
Read more
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases,...
Read more
Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved...
Read more
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced...
Read more
The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1...
Read more
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, announced that molecules in its NVP015 program have demonstrated positive effects in experimental...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
